Men's Health
Can You Take Tadalafil and Sildenafil Together?
Not on your own: combining two PDE5 inhibitors outside medical supervision adds blood-pressure and priapism risk with no physician watching the variables. Under a physician's direction it is a real, studied regimen, and compounded dual-ingredient capsules exist precisely so the combination happens as one prescribed, dosed decision rather than two pill bottles and a guess.
Reviewed by board-certified physicians · Published 2026-08-28 · Updated 2026-08-28 · 8 min read
Key facts
- Sildenafil and tadalafil share one mechanism, PDE5 inhibition, so combining them stacks the same pharmacology twice.
- The labels of Viagra® and Cialis® both advise against use with other PDE5 inhibitors.
- Published studies have examined physician-directed combinations, most commonly daily low-dose tadalafil plus as-needed sildenafil, in men with inadequate response to one drug.
- Compounded dual-ingredient capsules put fixed amounts of both molecules in a single prescribed dose. They are not FDA-approved products.
- The rationale for combining is the two molecules' different time profiles: short-acting coverage on demand layered on long-acting background.
Why is self-combining a bad idea when both drugs are so common?
Because the mechanism is identical, doubling up is closer to taking a larger dose of one drug than to adding something new, and the dose-related risks scale accordingly: blood-pressure lowering, headache, flushing, visual effects, and at the far end priapism, the emergency covered in our injection therapy guide. The labels of both branded products advise against combining PDE5 inhibitors, and every credible clinical source repeats it for unsupervised use.
The other reason is subtler: timing. Tadalafil remains active for well over a day, so a man who takes it and then adds sildenafil the next evening is combining them whether he thinks so or not. This catch applies to anyone switching between the two casually, which is exactly why the combination question deserves a physician rather than a forum consensus.
What does the actual research on combination therapy show?
The studied pattern is specific: daily low-dose tadalafil as background, with as-needed sildenafil layered on for individual occasions, in men whose response to a single agent at full dose was inadequate. Published trials and case series in this population report improved erectile function scores for a portion of men over single-agent therapy, with side effects broadly consistent with the class rather than multiplied, under protocol conditions with screening and supervision.
A careful reading of that literature: it is encouraging for a defined, physician-selected group; it is small compared with the enormous single-agent evidence base; and every study of it involves exactly the supervision the do-not-combine warnings call for. The research validates the supervised regimen, not the medicine-cabinet version.
What is a compounded dual-ingredient capsule, and why prescribe one?
A dual capsule contains fixed amounts of both tadalafil and sildenafil in a single dosage unit, prepared per prescription by a state-licensed compounding pharmacy. The design logic mirrors the studied regimen: one molecule for extended background presence, one for a defined onset window, in amounts the physician selects deliberately, taken as one dose that cannot be accidentally mistimed against itself.
The standard compounded-product disclosure applies in full: these capsules are not FDA-approved, carry no product-specific trials, and rest on the pharmacy's licensure and the prescriber's judgment. The active molecules are the same APIs as the approved tablets; the combination and format are what compounding contributes, and a legitimate prescriber can articulate why that combination fits you rather than a titrated single agent.